New strategy for COVID-19 vaccination: targeting the receptor

Targeting Tumor Glycans for Cancer Therapy - Glycopedia

COVID-19 - Wikipedia

COVID-19: Coronavirus replication, pathogenesis, and therapeutic

NCI's Research on COVID-19, Vaccines, and Antibodies - NCI

Novel vaccine strategy protects mice from COVID-19 and 4 related

Lipid-Based Poly(I:C) Adjuvants Strongly Enhance the Immunogenicity of SARS-CoV-2 Receptor-Binding Domain Vaccine

Junzhi Wang's research works National Institutes for Food and Drug Control, China, Beijing (NIFDC) and other places

Azvudine (FNC): a promising clinical candidate for COVID-19 treatment

Vaccination strategies and Therapeutic monoclonal antibodies (mAbs

Frontiers Potential Therapeutic Targets and Vaccine Development

Vaccines ++ – COVID Reference

PDF) Epigallocatechin gallate (EGCG) attenuates severe acute respiratory coronavirus disease 2 (SARS-CoV-2) infection by blocking the interaction of SARS-CoV-2 spike protein receptor-binding domain to human angiotensin-converting enzyme 2

Progress of the COVID-19 vaccine effort: viruses, vaccines and